Oncolytics Biotech Files 6-K Report
Ticker: ONCY · Form: 6-K · Filed: May 24, 2024 · CIK: 1129928
| Field | Detail |
|---|---|
| Company | Oncolytics Biotech INC (ONCY) |
| Form Type | 6-K |
| Filed Date | May 24, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, compliance
TL;DR
Oncolytics Biotech filed a routine 6-K, no major news.
AI Summary
Oncolytics Biotech Inc. filed a Form 6-K on May 24, 2024, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is in the pharmaceutical preparations industry and files annual reports under Form 20-F. This filing does not contain specific financial figures or operational updates beyond its classification and reporting status.
Why It Matters
This filing indicates Oncolytics Biotech Inc.'s ongoing compliance with SEC reporting requirements as a foreign private issuer, which is standard for companies with international operations.
Risk Assessment
Risk Level: low — This is a standard procedural filing by a foreign private issuer and does not contain new material information that would typically impact risk.
Key Players & Entities
- ONCOLYTICS BIOTECH INC (company) — Filer
- 20240524 (date) — Filing Date
- 001-38512 (other) — SEC File Number
- Calgary, Alberta, Canada (location) — Company Headquarters
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that provides information which the issuer makes or is required to make public pursuant to the laws of the issuer's home country, or which is made or is required to be made public to any stock exchange on which the issuer's securities are traded, or which is distributed or is required to be distributed to the security holders of the issuer.
What is Oncolytics Biotech Inc.'s standard reporting form for annual reports?
Oncolytics Biotech Inc. files its annual reports under cover of Form 20-F.
What industry is Oncolytics Biotech Inc. classified under?
Oncolytics Biotech Inc. is classified under the Pharmaceutical Preparations industry (SIC code 2834).
When was this Form 6-K filed?
This Form 6-K was filed on May 24, 2024.
Where is Oncolytics Biotech Inc. headquartered?
Oncolytics Biotech Inc. is headquartered in Calgary, Alberta, Canada.
Filing Stats: 334 words · 1 min read · ~1 pages · Grade level 17 · Accepted 2024-05-24 13:47:53
Filing Documents
- form6kascoabstracts2024.htm (6-K) — 18KB
- oncy2024ascopr.htm (EX-99.1) — 34KB
- 0001129928-24-000044.txt ( ) — 53KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Oncolytics Biotech Inc. (Registrant) By s Kirk Look Date May 24, 2024 Kirk Look Chief Financial Officer